![At the Intersection of Science and Law artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/51/39/8b/51398b0d-2f2f-8298-3b1a-7aabbd782582/mza_4353938871311776870.jpg/100x100bb.jpg)
Understanding AI and its use in drug discovery
At the Intersection of Science and Law
English - October 05, 2021 21:08 - 31 minutes - 29.2 MBLife Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
Next Episode: Social media’s impact on the life sciences industry
DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.
See omnystudio.com/listener for privacy information.